Stocks for the Bioelectronic Medicine Revolution (NVCR, EMED, ECOR)
Bioelectronic medicine is starting to gain widespread attention after years of skepticism. That skepticism is now being eroded by a growing wave of peer-reviewed...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) And Cheisi Submit BLA for PRX-102 in...
Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) and Chiesi Global Rare Diseases have announced that they have submitted a Biologics License Application to the FDA for pegunigalsidase...
MAKE IT MODERN
LATEST REVIEWS
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Expects To Post Revenues Of $245 Million...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) achieved several milestones in Q2 2020. CEO of Halozyme, Helen Torley, said the company also received FDA approval for partnered...
MAKE IT MODERN
PERFORMANCE TRAINING
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Topline Results Of AT-GAA In Phase 3, 52-Week Clinical...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) posted topline results in treating LOPD (Late-onset Pompe disease) using its AT-GAA in phase 3, 52-week clinical trial. The US...
GT Biopharma (GTBP) Reports Breakthrough Q1 Results: Stock Soars 150% Amid Promising Advances
GT Biopharma Inc. (NASDAQ: GTBP), a leading immuno-oncology company, has made significant strides in the first quarter of 2024, as highlighted in...
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Issues Investors and Stakeholders on the Update...
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) recently disclosed the status of its ongoing research on creating a reproducible clinical product of Imcelz. The...
BrideBio Pharma Inc. (NASDAQ:BBIO) Announces Its Q3 2020 Financial Results And Corporate Updates
BrideBio Pharma Inc. (NASDAQ:BBIO) has announced its Q3 2020 financial results and provided business highlights on its operations for the period.
BridgeBio to merge with...
Why Cannabinoid Stocks Could Emerge as 2022’s Big Winners (GLASF, SGMD, INM, CRON, AVCNF,...
As growth stocks take a hit to start off 2022, some of the most profound growth investment themes are on sale.
MAKE IT MODERN
